2024-511821-75-00RecruitingPhase 1/2
Dose escalation of allogeneic Adipose derived Stroma/stem Cells for the treatment of Crohn’s fistula
Source: EU CTIS (euclinicaltrials.eu) · Last updated 2 Feb 2026
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 9 (estimated)
- First submitted
- 31 May 2024
- Start date
- 13 Mar 2025
- Lead sponsor
- Centre Hospitalier Universitaire De Toulouse
- Diseases
- Crohn's disease
- EU CT number
- 2024-511821-75-00
What you commit to
- Study type: Interventional · Phase 1/2
- Planned participants: 9
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
AI-kivonat: who the study is looking for
Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with Crohn's fistula. It tests different doses of donor fat-derived stem cells.
- Age
- 18 years or older
- Sex
- All sexes can join
Read by machine on 9 Nov 2026.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre Hospitalier Universitaire De Toulouse | Toulouse Cedex 9 | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.